Childrens Hospital
- Type
- Teaching hospital
- Where
- Washington, DC
- Medicare CCN
- 093300
- Received
- $1,118,395 in 69 records, 2024 ($742,969 general, $375,426 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2024 | General payment | 45 | $742,969 |
| 2024 | Research payment | 24 | $375,426 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $650,000 | 2024 |
| Novartis Pharmaceuticals Corporation | 7 | $239,563 | 2024 |
| RADIOMETER AMERICA, INC | 5 | $65,391 | 2024 |
| CoapTech, Inc. | 1 | $35,482 | 2024 |
| Fisher Scientific Company L.L.C. | 15 | $28,887 | 2024 |
| Medtronic, Inc. | 5 | $26,413 | 2024 |
| Hikma Pharmaceuticals USA | 1 | $15,000 | 2024 |
| National Marrow Donor Program | 4 | $9,040 | 2024 |
| QIAGEN, LLC | 1 | $7,500 | 2024 |
| BioMarin Pharmaceutical Inc. | 1 | $6,500 | 2024 |
| Baxter Healthcare | 3 | $5,182 | 2024 |
| Merck Sharp & Dohme LLC | 2 | $5,000 | 2024 |
| PFIZER INC. | 2 | $5,000 | 2024 |
| GE HEALTHCARE | 1 | $4,300 | 2024 |
| ViiV Healthcare Company | 1 | $2,738 | 2024 |
| SANOFI PASTEUR INC. | 1 | $2,500 | 2024 |
| Neurelis, Inc. | 1 | $2,000 | 2024 |
| Greiner Bio-One North America, Inc. | 4 | $1,916 | 2024 |
| Linvatec Corporation | 1 | $1,505 | 2024 |
| Cochlear Americas | 1 | $1,501 | 2024 |
| Berlin Heart Inc | 1 | $1,200 | 2024 |
| Fisher & Paykel Healthcare Inc | 1 | $1,003 | 2024 |
| Dexcom, Inc. | 1 | $246 | 2024 |
| Olympus America Inc. | 4 | $221 | 2024 |
| Siemens Medical Solutions USA, Inc. | 2 | $147 | 2024 |
| LivaNova USA, Inc. | 1 | $98 | 2024 |
| JAZZ PHARMACEUTICALS INC. | 1 | $54 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Grant | 1 | $650,000 |
| Research payment | 24 | $375,426 |
| Debt forgiveness | 22 | $30,821 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 7 | $20,540 |
| Charitable Contribution | 1 | $15,000 |
| Space rental or facility fees (teaching hospital only) | 4 | $12,500 |
| Gift | 2 | $7,527 |
| Long term medical supply or device loan | 4 | $2,691 |
| Education | 1 | $2,000 |
| Travel and Lodging | 1 | $1,084 |
| Food and Beverage | 1 | $733 |
| Entertainment | 1 | $69 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | Linvatec Corporation | $1,505 | Long term medical supply or device loan | In-kind items and services | HALL POWER Device, ORTHOPEDIC SURGERY | 2024 | |
| 2024-12-31 | Fisher & Paykel Healthcare Inc | $1,003 | Long term medical supply or device loan | In-kind items and services | FISHER & PAYKEL HEALTHCARE Device, Heated respiratory humidifier | 2024 | |
| 2024-12-31 | Siemens Medical Solutions USA, Inc. | $110 | Debt forgiveness | In-kind items and services | 2024 | ||
| 2024-12-30 | Olympus America Inc. | $121 | Debt forgiveness | In-kind items and services | Gyrus ACMI Device, Ear, Nose, Throat | 2024 | |
| 2024-12-30 | Siemens Medical Solutions USA, Inc. | $37 | Research payment | In-kind items and services | Artis zee multi-purpose Device, AT - Fixed interventional x-ray/angiography fluoroscopy | CNMC Kanter AX Interventional Cardiology | 2024 |
| 2024-12-16 | PFIZER INC. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-12-13 | Greiner Bio-One North America, Inc. | $733 | Food and Beverage | In-kind items and services | VACUETTE Device, IVD | 2024 | |
| 2024-12-13 | Greiner Bio-One North America, Inc. | $69 | Entertainment | In-kind items and services | VACUETTE Device, IVD | 2024 | |
| 2024-12-13 | Greiner Bio-One North America, Inc. | $27 | Gift | In-kind items and services | VACUETTE Device, IVD | 2024 | |
| 2024-12-12 | Merck Sharp & Dohme LLC | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | GARDASIL Biological, VACCINE | 2024 | |
| 2024-12-06 | Baxter Healthcare | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Renal - Acute Device, Renal | 2024 | |
| 2024-11-27 | Novartis Pharmaceuticals Corporation | $18,723 | Research payment | Cash or cash equivalent | A One Month, Investigator and Participant Blinded Study to Investigate the Efficacy and Safety of Remibrutinib (LOU064) | 2024 | |
| 2024-11-22 | Fisher Scientific Company L.L.C. | $227 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-11-20 | BioMarin Pharmaceutical Inc. | $6,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOXZOGO 1.2mg Drug, Achondroplasia | 2024 | |
| 2024-10-30 | Olympus America Inc. | $4 | Debt forgiveness | In-kind items and services | Gyrus ACMI Device, Ear, Nose, Throat | 2024 | |
| 2024-10-25 | National Marrow Donor Program | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-10-18 | Greiner Bio-One North America, Inc. | $1,084 | Travel and Lodging (2 payments) | In-kind items and services | VACUETTE Device, IVD | 2024 | |
| 2024-10-03 | QIAGEN, LLC | $7,500 | Gift | Cash or cash equivalent | 2024 | ||
| 2024-09-01 | Medtronic, Inc. | $10,753 | Research payment | In-kind items and services | Investigator Sponsored Research | 2024 | |
| 2024-09-01 | Medtronic, Inc. | $6,519 | Research payment | In-kind items and services | Investigator Sponsored Research | 2024 | |
| 2024-09-01 | Medtronic, Inc. | $5,798 | Research payment | In-kind items and services | Investigator Sponsored Research | 2024 | |
| 2024-09-01 | Medtronic, Inc. | $1,932 | Research payment | In-kind items and services | Investigator Sponsored Research | 2024 | |
| 2024-09-01 | Medtronic, Inc. | $1,408 | Research payment | In-kind items and services | Investigator Sponsored Research | 2024 | |
| 2024-08-31 | CoapTech, Inc. | $35,482 | Research payment | Cash or cash equivalent | PUMA SYSTEM Device, Gastrostomy Tube Placement Kit | Pediatric Percutaneous Ultrasound Gastrostomy Technique | 2024 |
| 2024-08-23 | Fisher Scientific Company L.L.C. | $788 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-08-23 | Fisher Scientific Company L.L.C. | $171 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-08-23 | Fisher Scientific Company L.L.C. | $41 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-08-12 | Berlin Heart Inc | $1,200 | Research payment | Cash or cash equivalent | Device | EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study | 2024 |
| 2024-07-26 | National Marrow Donor Program | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-07-18 | Novartis Pharmaceuticals Corporation | $20,774 | Research payment | In-kind items and services | XOLAIR Drug, Pulmonary/Respiratory Diseases | Omalizumab Before Onset of Exacerbations URI-induc. asthma exacerbation | 2024 |
| 2024-06-28 | Olympus America Inc. | $60 | Debt forgiveness | In-kind items and services | SINGLE USE SUCTION VALVE (Sterile) Device, Endotherapy | 2024 | |
| 2024-06-21 | LivaNova USA, Inc. | $98 | Debt forgiveness | Cash or cash equivalent | Perfusion Tubing Device, Cardiology/Vascular Diseases | 2024 | |
| 2024-06-18 | Dexcom, Inc. | $246 | Research payment | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | CAMP: CGM-Assisted Management of PN | 2024 |
| 2024-06-01 | RADIOMETER AMERICA, INC | $24,742 | Research payment | Cash or cash equivalent | TCM CombiM module Device, Devices | Evaluation of Clinical Decision Support Tools for Ventilation Management in the NICU | 2024 |
| 2024-05-22 | GE HEALTHCARE | $4,300 | Research payment | Cash or cash equivalent | Ultrasound Study | 2024 | |
| 2024-05-21 | RADIOMETER AMERICA, INC | $9,746 | Research payment | In-kind items and services | TCM CombiM module Device, Devices | Evaluation of Clinical Decision Support Tools for Ventilation Management in the NICU | 2024 |
| 2024-05-17 | Fisher Scientific Company L.L.C. | $21,336 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-05-17 | Fisher Scientific Company L.L.C. | $1,976 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-05-17 | Fisher Scientific Company L.L.C. | $1,043 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-05-16 | Merck Sharp & Dohme LLC | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | GARDASIL Biological, VACCINE | 2024 | |
| 2024-05-08 | PFIZER INC. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-05-06 | Baxter Healthcare | $94 | Long term medical supply or device loan | In-kind items and services | Hillrom - Spot Vision Screener Device, Physical Assessment, Vision | 2024 | |
| 2024-05-03 | Novartis Pharmaceuticals Corporation | $31,296 | Research payment | Cash or cash equivalent | MAYZENT Drug, Neurology | A 2-year Randomized, 3-arm, Double-blind, Non-inferiority Study Comparing the Efficacy and Safety of Ofatumumab and Sipo | 2024 |
| 2024-05-03 | Novartis Pharmaceuticals Corporation | $12,500 | Research payment | Cash or cash equivalent | ZOLGENSMA Drug, Neurology | A Randomized, Sham-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Intrathecal OAV101 in Patients | 2024 |
| 2024-05-03 | Neurelis, Inc. | $2,000 | Education | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-04-26 | National Marrow Donor Program | $875 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-04-23 | Baxter Healthcare | $88 | Long term medical supply or device loan | In-kind items and services | Hillrom - Spot Vision Screener Device, Physical Assessment, Vision | 2024 | |
| 2024-04-22 | SANOFI PASTEUR INC. | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2024 | ||
| 2024-04-04 | Cochlear Americas | $1,501 | Debt forgiveness (2 payments) | Cash or cash equivalent | COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE Device, Implantable hearing solution | 2024 | |
| 2024-03-29 | Olympus America Inc. | $35 | Debt forgiveness | In-kind items and services | Gyrus ACMI Device, Ear, Nose, Throat | 2024 | |
| 2024-03-21 | ViiV Healthcare Company | $2,738 | Research payment | Cash or cash equivalent | PHASE 1/2 STUDY OF SWITCHING TO FIXED DOSE COMBINATION DOLUTEGRAVIR/RI | 2024 | |
| 2024-02-27 | RADIOMETER AMERICA, INC | $7,622 | Research payment | In-kind items and services | TCM CombiM module Device, Devices | Evaluation of Clinical Decision Support Tools for Ventilation Management in the NICU | 2024 |
| 2024-02-23 | Fisher Scientific Company L.L.C. | $1,649 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-02-23 | Fisher Scientific Company L.L.C. | $541 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-02-23 | Fisher Scientific Company L.L.C. | $446 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-02-23 | Fisher Scientific Company L.L.C. | $236 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-02-23 | Fisher Scientific Company L.L.C. | $195 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-02-23 | Fisher Scientific Company L.L.C. | $103 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-02-23 | Fisher Scientific Company L.L.C. | $81 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-02-23 | Fisher Scientific Company L.L.C. | $48 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-02-16 | RADIOMETER AMERICA, INC | $23,000 | Research payment | In-kind items and services | TCM CombiM module Device, Devices | Evaluation of Clinical Decision Support Tools for Ventilation Management in the NICU | 2024 |
| 2024-02-16 | RADIOMETER AMERICA, INC | $280 | Research payment | In-kind items and services | TCM CombiM module Device, Devices | Evaluation of Clinical Decision Support Tools for Ventilation Management in the NICU | 2024 |
| 2024-01-19 | Takeda Pharmaceuticals U.S.A., Inc. | $650,000 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-01-15 | Novartis Pharmaceuticals Corporation | $31,356 | Research payment | Cash or cash equivalent | KYMRIAH Drug, Oncology | A single arm phase II trial in first line high risk HR pediatric and young adult patients with Bcell acute lymphoblastic | 2024 |
| 2024-01-12 | National Marrow Donor Program | $3,865 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-01-10 | Novartis Pharmaceuticals Corporation | $13,853 | Research payment | Cash or cash equivalent | TAFINLAR Drug, Oncology | An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabr | 2024 |
| 2024-01-09 | JAZZ PHARMACEUTICALS INC. | $54 | Research payment | Cash or cash equivalent | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | A Phase 1/2, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Recommended Phase 2 Dose (RP2 | 2024 |
| 2024-01-05 | Novartis Pharmaceuticals Corporation | $111,058 | Research payment | Cash or cash equivalent | ADAKVEO Drug, Hematology | An Open-label, Multi-center, Phase IV, Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior N | 2024 |
| 2024-01-01 | Hikma Pharmaceuticals USA | $15,000 | Charitable Contribution | Cash or cash equivalent | 2024 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Washington, DC, county District of Columbia, DC, state District of Columbia; placed by its city name.
| Measure | Place (city or town) Washington, DC | County District of Columbia, DC | State District of Columbia |
|---|---|---|---|
| Population B01003 | 681,294 | 681,294 | 681,294 |
| Population, 2020 census P1 | 689,545 | 689,545 | 689,545 |
| Median age B01002 | 34.9 | 34.9 | 34.9 |
| Under 18 B01001 | 18.7% | 18.7% | 18.7% |
| 65 and over B01001 | 12.8% | 12.8% | 12.8% |
| Households B11001 | 324,491 | 324,491 | 324,491 |
| Foreign born B05002 | 14.3% | 14.3% | 14.3% |
| Median household income B19013 | $109,870 | $109,870 | $109,870 |
| Median family income B19113 | $155,025 | $155,025 | $155,025 |
| Per capita income B19301 | $77,348 | $77,348 | $77,348 |
| Poverty rate B17001 | 15.4% | 15.4% | 15.4% |
| Unemployment rate B23025 | 6.3% | 6.3% | 6.3% |
| Civilian labor force B23025 | 400,406 | 400,406 | 400,406 |
| Mean commute (minutes) B08013 | 30.0 | 30.0 | 30.0 |
| Bachelor's degree or higher B15003 | 64.2% | 64.2% | 64.2% |
| Housing units B25001 | 361,014 | 361,014 | 361,014 |
| Owner-occupied B25003 | 41.5% | 41.5% | 41.5% |
| Renters B25003 | 58.5% | 58.5% | 58.5% |
| Median home value B25077 | $737,100 | $737,100 | $737,100 |
| Median gross rent B25064 | $1,954 | $1,954 | $1,954 |
| White, not Hispanic B03002 | 36.5% | 36.5% | 36.5% |
| Black B03002 | 41.6% | 41.6% | 41.6% |
| Hispanic or Latino B03002 | 11.9% | 11.9% | 11.9% |
| Asian B03002 | 4.3% | 4.3% | 4.3% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Economy now FRED unemployment 5.6% in Sep 2026 (6.6% a year earlier); per capita personal income $119,772 in 2025, up 32% in five years (+6.5% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Washington, DC.
Comments